X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1415) 1415
ursodeoxycholic acid (1136) 1136
male (968) 968
female (841) 841
ursodeoxycholic acid - therapeutic use (660) 660
gastroenterology & hepatology (639) 639
ursodeoxycholic acid - administration & dosage (618) 618
index medicus (593) 593
middle aged (568) 568
adult (543) 543
animals (502) 502
aged (348) 348
treatment outcome (292) 292
cholagogues and choleretics - therapeutic use (282) 282
ursodeoxycholic acid - pharmacology (280) 280
primary biliary-cirrhosis (268) 268
rats (260) 260
liver (251) 251
cholagogues and choleretics - administration & dosage (244) 244
cholestasis (242) 242
liver cirrhosis, biliary - drug therapy (239) 239
ursodiol (229) 229
pharmacology & pharmacy (226) 226
bile (222) 222
drug therapy, combination (190) 190
bile acids and salts - metabolism (174) 174
bile acids (171) 171
bile-acids (165) 165
chenodeoxycholic acid (163) 163
administration, oral (160) 160
liver - metabolism (160) 160
time factors (159) 159
mice (148) 148
primary biliary cirrhosis (148) 148
primary sclerosing cholangitis (142) 142
double-blind (141) 141
liver - pathology (139) 139
therapy (139) 139
liver - drug effects (138) 138
risk factors (136) 136
deoxycholic acid - analogs & derivatives (133) 133
disease (131) 131
liver diseases (127) 127
cholelithiasis - drug therapy (126) 126
dose-response relationship, drug (125) 125
metabolism (124) 124
care and treatment (122) 122
liver function tests (121) 121
medicine, general & internal (120) 120
bile acids and salts - blood (119) 119
acids (118) 118
follow-up studies (118) 118
apoptosis (110) 110
gastroenterology and hepatology (110) 110
cholesterol (103) 103
double-blind method (103) 103
pregnancy (103) 103
adolescent (101) 101
research (101) 101
surgery (101) 101
ursodeoxycholic acid - adverse effects (101) 101
cholelithiasis - therapy (100) 100
chenodeoxycholic acid - administration & dosage (99) 99
bile - metabolism (97) 97
liver transplantation (96) 96
chenodeoxycholic acid - therapeutic use (94) 94
rodents (94) 94
prospective studies (90) 90
cirrhosis (88) 88
cholangitis, sclerosing - drug therapy (87) 87
disease models, animal (87) 87
expression (85) 85
health aspects (85) 85
liver-disease (85) 85
rats, sprague-dawley (85) 85
rats, wistar (85) 85
drug administration schedule (84) 84
gallstones (84) 84
oncology (84) 84
placebo-controlled trial (84) 84
medicine, research & experimental (81) 81
child (80) 80
prognosis (79) 79
cholestasis - drug therapy (77) 77
cholesterol - metabolism (77) 77
oxidative stress (76) 76
diagnosis (74) 74
alanine transaminase - blood (73) 73
bilirubin - blood (73) 73
alkaline phosphatase - blood (72) 72
cholagogues and choleretics - pharmacology (72) 72
biochemistry & molecular biology (70) 70
pediatrics (69) 69
retrospective studies (69) 69
deoxycholic acid (67) 67
cholestasis, intrahepatic - drug therapy (66) 66
liver cirrhosis, biliary - complications (65) 65
aged, 80 and over (64) 64
gastroenterology (63) 63
ursodeoxycholic acid - analogs & derivatives (63) 63
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1812) 1812
German (72) 72
Russian (61) 61
Japanese (56) 56
Spanish (20) 20
French (18) 18
Chinese (8) 8
Italian (8) 8
Korean (8) 8
Polish (6) 6
Danish (4) 4
Czech (3) 3
Swedish (3) 3
Ukrainian (3) 3
Dutch (2) 2
Bulgarian (1) 1
Hebrew (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Gastroenterology, ISSN 0016-5085, 2015, Volume 148, Issue 4, pp. 751 - 761.e8
Journal Article
Journal Article
Journal of Hepatology, ISSN 0168-8278, 2015, Volume 62, Issue 6, pp. 1398 - 1404
Graphical abstract 
Gastroenterology and Hepatology | 3-hydroxy-3-methylglutaryl-CoA reductase | Stearoyl-CoA desaturase | Non-alcoholic fatty liver disease | Lipogenesis | FGF19 | 3-hydroxy-3-methylglutaryl- CoA reductase | Ursodeoxycholic Acid - administration & dosage | Oleic Acid - metabolism | Bile Acids and Salts - biosynthesis | Humans | Liver - metabolism | Bile Acids and Salts - metabolism | Non-alcoholic Fatty Liver Disease - metabolism | Intra-Abdominal Fat - metabolism | Obesity, Morbid - drug therapy | Non-alcoholic Fatty Liver Disease - drug therapy | Ursodeoxycholic Acid - pharmacology | Stearoyl-CoA Desaturase - biosynthesis | Liver - drug effects | Receptors, Cytoplasmic and Nuclear - antagonists & inhibitors | Lipid Metabolism - drug effects | Intra-Abdominal Fat - drug effects | Obesity, Morbid - metabolism | Physiological aspects | Obesity | Ursodiol | Deoxycholic acid | Index Medicus | BAs, bile acids | nCEH, neutral cholesterol ester hydrolase | ApoB, apolipoprotein B | LDLR, low density lipoprotein receptor | FGF19, fibroblast growth factor 19 | VLDL, very low density lipoproteins | ABC, ATP-binding cassette | TGs, triglycerides | NAFLD, non-alcoholic fatty liver disease | OA, oleic acid | C4, 7α-hydroxy-4-cholesten-3-one | SHP, small heterodimer partner | SREBP1c, sterol regulatory element-binding protein-1c | CA, cholic acid | PA, palmitic acid | FATP1, fatty acid transport protein 1 | UDCA, ursodeoxycholic acid | FAs, fatty acides | HMGCR, 3-hydroxy-3-methylglutaryl-CoA reductase | vWAT, visceral white adipose tissue | SCD, stearoyl-Coa desaturase | CYP7A1, cholesterol 7α-hydroxylase | NASH, non-alcoholic steatohepatitis | FXR, farnesoid X receptor | CDCA, chenodeoxycholic acid | MA, myristic acid | FASN, fatty acid synthase | MTTP, microsomal triglyceride transfer protein | SA, stearic acid | NONALCOHOLIC | FATTY LIVER-DISEASE | NUCLEAR RECEPTOR | CHOLESTEROL-METABOLISM | Gastroenterology & Hepatology | TRANSPORT | Endokrinologi och diabetes | FEEDBACK-REGULATION | STEATOHEPATITIS | PLACEBO-CONTROLLED TRIAL | COA DESATURASE | EXPRESSION | Endocrinology and Diabetes | ADIPOSE-TISSUE
Journal Article
The American Journal of Gastroenterology, ISSN 0002-9270, 09/2011, Volume 106, Issue 9, pp. 1638 - 1645
Journal Article
Journal of Hepatology, ISSN 0168-8278, 2011, Volume 54, Issue 5, pp. 1011 - 1019
Journal Article
Journal Article
FASEB Journal, ISSN 0892-6638, 09/2017, Volume 31, Issue 9, pp. 3848 - 3857
Journal Article